Avita Medical Limited has concluded a deal with Mintcare, which specializes in the distribution of wound care products throughout the Asia-Pacific region. Avita Medical said Mintcare would first focus on Malaysia in its marketing of Avita’s regenerative medical devices for burns, wounds and skin conditions.
Mintcare has a four-person sales force in the Southeast Asian country, where vitiligo alone is reported to affect an estimated 450,000 people, chronic wounds some 180,000 patients, and large burns annually leave about 1,200 Malaysians hospitalized.
Avita Medical’s ReCell technology works through the rapid delivery of viable cells harvested from a piece of the patient’s own skin and is administered by spraying the cells onto the affected area to trigger healing. ReCell will be launched at an international wound care conference in Sabah, Malaysia in August. Singapore-based Mintcare also has commercial presence in Hong Kong, Indonesia, Philippines, Sri Lanka, Thailand, and Vietnam, and its range includes wound care products that complement Avita’s offering.
“Mintcare has successfully developed a distribution network in Southeast Asia specifically in the chronic wound care field, primarily targeting diabetic foot ulcers and venous leg ulcers with topical oxygen therapy,” Lamine Guendil, Mintcare director, said in a statement.
In recent months, Avita Medical has announced distribution agreements with parties in China, Japan and South Korea, and it has been active in Taiwan, where it donated devices following a mass casualty event last summer in a waterpark that left some 500 people burned.
